Clinical trials
Phase 2 Genital Neoplasms, Male trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 4 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| NanOlogy, LLC | 2 |
| Steba Biotech S.A. | 2 |
| Alessandro D'Agnolo | 1 |
| Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 1 |
| Cedars-Sinai Medical Center | 1 |
| Dendreon | 1 |
| Institut Claudius Regaud | 1 |
| Nasser Hanna, M.D. | 1 |
| Novartis Pharmaceuticals | 1 |
| Promontory Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genital Neoplasms, Male | 12 |
| Prostatic Neoplasms | 10 |
| Urogenital Neoplasms | 10 |
| Prostatic Diseases | 8 |
| Neoplasms | 5 |
| Neoplasms by Site | 5 |
| Carcinoma | 4 |
| Genital Diseases, Male | 4 |
| Adenocarcinoma | 2 |
| Male Urogenital Diseases | 2 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.